{"gene":"CLCN4","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2005,"finding":"ClC-4 functions as a secondary active Cl⁻/H⁺ antiporter (not a classical Cl⁻ channel), transporting protons against their electrochemical gradient coupled to Cl⁻ movement; mutation of the pore glutamate E211A abolishes H⁺ but not Cl⁻ transport, identifying this residue as essential for proton transport.","method":"pH measurements near cell surface in Xenopus oocytes; site-directed mutagenesis (E211A) with electrophysiology","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay with mutagenesis, highly cited foundational paper","pmids":["16034421"],"is_preprint":false},{"year":1999,"finding":"ClC-4 directly mediates strongly outwardly rectifying anion currents with a NO₃⁻ > Cl⁻ > Br⁻ > I⁻ conductance sequence; point mutations (including E224A in ClC-4) alter voltage dependence and ion selectivity, confirming direct channel-mediated currents.","method":"Xenopus oocyte and HEK293 electrophysiology; site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — electrophysiology with mutagenesis, highly cited","pmids":["9873029"],"is_preprint":false},{"year":2003,"finding":"ClC-4 is expressed in endosomal membranes; antisense-mediated disruption of endogenous ClC-4 acidifies endosomal pH and alters transferrin trafficking; ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they may function as a channel complex in endosomes.","method":"Confocal microscopy; antisense knockdown; endosomal pH measurement; co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (co-IP, KD with functional readout, imaging) in single lab","pmids":["12746443"],"is_preprint":false},{"year":2003,"finding":"ClC-4 exhibits unique pore properties including voltage-dependent unitary conductance (~0.10 pA at +140 mV) and distinct conductivity/permeability sequences for anions, with permeability increasing for anions with lower dehydration energies.","method":"Whole-cell patch-clamp recording; variance analysis; ion substitution experiments in tsA201/HEK293 cells","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — quantitative single-channel and macroscopic electrophysiology with multiple ion conditions","pmids":["12668439"],"is_preprint":false},{"year":2002,"finding":"Recombinant human ClC-4 generates a small-conductance (~3 pS), strongly outward-rectifying Cl⁻ channel whose activity requires ATP (with hydrolysis needed for full activity); external acidification inhibits currents with half-maximal inhibition at ~pH 6.19; Ca²⁺ has no effect.","method":"Patch-clamp electrophysiology in multiple mammalian cell lines; single-channel recordings; nucleotide substitution experiments","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — detailed electrophysiological characterization with multiple pharmacological and ionic conditions","pmids":["11882671"],"is_preprint":false},{"year":2001,"finding":"ClC-4 co-localizes with CFTR in the brush border membrane of intestinal epithelial cells and partially with endosomal markers; antisense knockdown of endogenous ClC-4 reduces Cl⁻ current amplitude by 50%, demonstrating functional expression at the plasma membrane of enterocytes.","method":"Confocal and electron microscopy; antisense knockdown; electrophysiology","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional consequence via knockdown electrophysiology","pmids":["11675385"],"is_preprint":false},{"year":2004,"finding":"ClC-4 promotes copper incorporation into ceruloplasmin; ClC-4 overexpression doubles holoCp secretion (more than 4-fold under copper-limiting conditions), while ClC-3 overexpression has no effect; ClC-4 co-immunoprecipitates with ATP7B (Wilson's disease protein) and co-localizes with it in intracellular vesicles.","method":"Co-overexpression with ceruloplasmin; gel electrophoresis/immunoblot; co-immunoprecipitation; subcellular fractionation/confocal microscopy","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional overexpression assay with specific isoform controls","pmids":["15057754"],"is_preprint":false},{"year":2006,"finding":"Human ClC-4 localizes to the endoplasmic reticulum/sarcoplasmic reticulum (not vesicular structures like ClC-3) when heterologously expressed; a stretch of N-terminal residues (aa 14–63) constitutes a novel motif necessary and sufficient for ER targeting.","method":"Heterologous expression in HEK293 and skeletal muscle fibers; subcellular fractionation; truncation and chimera constructs; confocal imaging","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — localization determined by direct fractionation and imaging, with structure-function mapping via chimeras/truncations","pmids":["17023393"],"is_preprint":false},{"year":2008,"finding":"Zn²⁺ inhibits ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site involving three consecutive histidine residues in an extracellular loop; mutations of these histidines reduce Zn²⁺ inhibition; alterations of transport properties (permeant ions, gating glutamate mutation) also affect Zn²⁺ inhibition.","method":"Xenopus oocyte electrophysiology; site-directed mutagenesis of candidate histidine residues; ion substitution","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of multiple candidate residues with quantitative functional assays","pmids":["18658230"],"is_preprint":false},{"year":2009,"finding":"ClC-4-null fibroblasts show alkaline endosomal pH, reduced transferrin (Tfn) receptor-mediated uptake despite slightly increased Tfn receptor surface expression; the iron-release defect (a pH-dependent step) can be rescued by the iron chelator deferoxamine; ClC-4 depletion has no effect on EGFR trafficking to lysosomes, demonstrating a specific role in recycling endosomes.","method":"Primary fibroblasts from Clcn4-null mice; endosomal pH measurement; transferrin uptake assays; surface biotinylation; deferoxamine rescue; EGF trafficking comparison","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — KO model with multiple orthogonal readouts and specific rescue experiment","pmids":["19339555"],"is_preprint":false},{"year":2017,"finding":"ClC-4 is retained in the ER upon overexpression alone but is sorted to late endosomes/lysosomes or recycling endosomes depending on which ClC-3 splice variant it heterodimerizes with; in Clcn3-null astrocytes, ClC-4 is retained in the ER; native gel electrophoresis shows ClC-4 mostly as monomer with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers.","method":"Heterologous expression; confocal imaging in WT and Clcn3⁻/⁻ astrocytes; high-resolution clear native gel electrophoresis; co-expression of ClC-3 splice variants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, epistasis via Clcn3 KO, biochemical oligomerization analysis","pmids":["28972156"],"is_preprint":false},{"year":2022,"finding":"Pathogenic CLCN4 missense variants cause either loss-of-function (voltage-dependent activation shifted to more positive voltages) or gain-of-function (disrupted gate allowing inward transport at negative voltages); 15/59 variants showed LOF and 9 showed toxic GOF by electrophysiology.","method":"Xenopus oocyte two-electrode voltage-clamp; extended voltage and pH ranges; functional analysis of 59 variants","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 1 — large-scale electrophysiological functional analysis across 59 variants with mechanistic classification","pmids":["36385166"],"is_preprint":false},{"year":2022,"finding":"Disease-causing CLCN4 mutations can impair ClC-4 ion transport, alter subcellular trafficking, and/or impair heterodimerization with ClC-3; even subtle functional changes to endosomal Cl⁻/H⁺ exchange cause serious neurological symptoms.","method":"Heterologous expression in mammalian cells; patch-clamp electrophysiology; biochemistry; confocal imaging; analysis of 12 CLCN4 variants","journal":"Frontiers in molecular neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across many variants in mammalian cells","pmids":["35721313"],"is_preprint":false},{"year":2024,"finding":"TMEM9B directly interacts with ClC-3 and ClC-4 transporters (demonstrated by FLIM-FRET), and co-expression of TMEM9B dramatically reduces ClC-3 and ClC-4 transporter activity in Xenopus oocytes and HEK cells, while having little effect on ClC-7 or ClC-1, identifying TMEM9B as a specific regulatory accessory subunit for ClC-3/ClC-4.","method":"Xenopus oocyte electrophysiology; whole-cell patch-clamp in HEK cells; FLIM-FRET; co-expression studies","journal":"Life (Basel, Switzerland)","confidence":"High","confidence_rationale":"Tier 1–2 — FRET-based direct interaction evidence combined with functional electrophysiology in two systems with isoform specificity controls","pmids":["39202776"],"is_preprint":false},{"year":2025,"finding":"Certain pathogenic CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing transport activity of the heteromeric complex; this provides a molecular explanation for severe phenotypes in heterozygous females.","method":"Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in mammalian cells; bicistronic IRES co-expression of ClC-3 and ClC-4 variants","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1–2 — functional electrophysiology in two systems, single lab, novel mechanistic finding","pmids":["41439993"],"is_preprint":false},{"year":2025,"finding":"CLCN4 variants in human neurons cause early-stage neuronal cell death associated with altered endo-lysosomal dynamics and disrupted autophagic flux; MEG3 lncRNA is downregulated in CLCN4-variant neurons and its restoration rescues cellular defects and neuronal survival.","method":"Brain organoids and iPSC-derived neurons with patient CLCN4 variants; transcriptomic profiling; MEG3 rescue experiments; autophagic flux assays","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — preprint, single lab, novel pathway (autophagy/MEG3) not yet peer-reviewed","pmids":["bio_10.1101_2025.07.16.665078"],"is_preprint":true},{"year":2025,"finding":"Clcn4 knockout mice display reduced social interaction, increased repetitive behaviors, abnormal dendritic spine formation, reduced dendritic branching, and decreased phosphorylation of SYNAPSIN, PSD95, ERK, and CREB, as well as reduced CDK5 expression, demonstrating a role for ClC-4 in synaptic plasticity and neuronal morphology.","method":"Clcn4 KO mice (exon 5 deletion); behavioral tests; RNA-seq of mouse NPCs; immunoblot; Sholl analysis; cortical neuron culture","journal":"Translational psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — KO model with multiple biochemical and morphological readouts, single lab","pmids":["39863599"],"is_preprint":false},{"year":2024,"finding":"The CLCN4 p.(Gly342Arg) variant impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of transport activation by ~20 mV, with p.(Asp89Asn) constituting a gain-of-transport-function variant, demonstrating that both LOF and GOF ClC-4 variants cause epilepsy and developmental encephalopathy.","method":"Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods, single lab, clear mechanistic distinctions between variants","pmids":["38578438"],"is_preprint":false}],"current_model":"ClC-4 is a vesicular 2Cl⁻/H⁺ antiporter that localizes to the endoplasmic reticulum when expressed alone but is sorted to distinct endosomal compartments (recycling endosomes, late endosomes/lysosomes) upon heterodimerization with specific ClC-3 splice variants; its antiporter activity requires a critical pore glutamate (E211), is regulated by the accessory protein TMEM9B, acidifies endosomal lumen to support transferrin receptor cycling and copper incorporation into ceruloplasmin, and pathogenic CLCN4 variants cause neurodevelopmental disease through loss-of-function, gain-of-function, or dominant-negative effects within ClC-3/ClC-4 heterodimers."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that ClC-4 directly conducts strongly outwardly rectifying anion currents with a defined selectivity sequence resolved whether the protein was itself an ion-conducting entity or merely a regulator.","evidence":"Xenopus oocyte and HEK293 electrophysiology with site-directed mutagenesis (E224A)","pmids":["9873029"],"confidence":"High","gaps":["Transport stoichiometry and whether H⁺ coupling occurs were not addressed","Native cellular context not tested"]},{"year":2002,"claim":"Detailed biophysical characterization revealed that ClC-4 requires ATP for full activity and is inhibited by extracellular acidification, establishing regulatory parameters relevant to endosomal function.","evidence":"Patch-clamp electrophysiology with single-channel recordings and nucleotide substitution in mammalian cells","pmids":["11882671"],"confidence":"High","gaps":["Whether ATP acts directly on the protein or through a signaling intermediate was not resolved","Physiological relevance of pH inhibition in endosomes not yet tested"]},{"year":2003,"claim":"Localization of ClC-4 to endosomal membranes and demonstration that its depletion alkalinizes endosomal pH and impairs transferrin trafficking established ClC-4 as a functionally important endosomal transporter.","evidence":"Confocal microscopy, antisense knockdown, endosomal pH measurement, and co-immunoprecipitation with ClC-5","pmids":["12746443"],"confidence":"Medium","gaps":["Antisense approach lacks genetic specificity","Co-IP with ClC-5 not validated by reciprocal pull-down or in-vivo crosslinking"]},{"year":2004,"claim":"Discovery that ClC-4 promotes copper loading of ceruloplasmin and co-immunoprecipitates with the copper transporter ATP7B revealed a specific role in metal homeostasis distinct from ClC-3.","evidence":"Overexpression of ClC-4 vs. ClC-3 with ceruloplasmin; co-IP with ATP7B; confocal co-localization","pmids":["15057754"],"confidence":"Medium","gaps":["Loss-of-function validation of copper phenotype not performed","Co-IP without reciprocal validation"]},{"year":2005,"claim":"Reclassification of ClC-4 from a Cl⁻ channel to a secondary active Cl⁻/H⁺ antiporter — with identification of E211 as the critical proton-coupling glutamate — fundamentally redefined its molecular mechanism.","evidence":"pH measurements near cell surface in Xenopus oocytes; E211A mutagenesis with electrophysiology","pmids":["16034421"],"confidence":"High","gaps":["Transport stoichiometry not directly determined for ClC-4","Reconstitution in proteoliposomes not performed"]},{"year":2006,"claim":"Mapping an N-terminal ER-retention motif (aa 14–63) explained why ClC-4 localizes to the ER when expressed alone, raising the question of what mechanism reroutes it to endosomes in vivo.","evidence":"Truncation and chimera constructs with confocal imaging and subcellular fractionation in HEK293 and skeletal muscle fibers","pmids":["17023393"],"confidence":"High","gaps":["Partner-dependent re-routing not yet identified","ER retention motif sequence determinants not mapped to specific residues"]},{"year":2008,"claim":"Identification of an extracellular Zn²⁺ inhibition site involving three consecutive histidines provided the first structural insight into ClC-4 regulation by divalent cations.","evidence":"Xenopus oocyte electrophysiology with systematic histidine mutagenesis and ion substitution","pmids":["18658230"],"confidence":"High","gaps":["Physiological relevance of Zn²⁺ inhibition in endosomal lumen not established","No structural data to confirm binding site geometry"]},{"year":2009,"claim":"Clcn4-knockout fibroblasts with alkalinized endosomes and impaired transferrin uptake — but normal EGF/lysosome trafficking — genetically confirmed a specific role for ClC-4 in recycling-endosome acidification and iron release.","evidence":"Clcn4-null mouse primary fibroblasts; endosomal pH measurement; transferrin and EGF trafficking assays; deferoxamine rescue","pmids":["19339555"],"confidence":"High","gaps":["In vivo neuronal phenotype not assessed in this study","Contribution of ClC-3 compensation not evaluated"]},{"year":2017,"claim":"Demonstration that ClC-3 splice variants redirect ClC-4 from the ER to distinct endosomal compartments via heterodimerization resolved the long-standing puzzle of ClC-4's ER retention and established ClC-3/ClC-4 heterodimers as the physiologically relevant species.","evidence":"Co-expression in WT and Clcn3⁻/⁻ astrocytes; clear native gel electrophoresis; confocal imaging","pmids":["28972156"],"confidence":"High","gaps":["Determinants within ClC-3 that dictate sorting destination not mapped","Endogenous stoichiometry of heterodimers vs. homodimers in neurons unknown"]},{"year":2022,"claim":"Systematic electrophysiological analysis of 59 pathogenic CLCN4 variants established that neurodevelopmental disease arises through mechanistically distinct loss-of-function and gain-of-function mechanisms, explaining clinical heterogeneity.","evidence":"Xenopus oocyte two-electrode voltage-clamp of 59 variants; extended voltage and pH protocols","pmids":["36385166","35721313"],"confidence":"High","gaps":["Correlation between variant class and clinical severity not fully resolved","Effects on ClC-3/ClC-4 heterodimer function not assessed for all variants"]},{"year":2024,"claim":"Identification of TMEM9B as a direct interactor that specifically inhibits ClC-3/ClC-4 transport revealed a previously unknown accessory subunit-based regulatory mechanism for endosomal Cl⁻/H⁺ exchange.","evidence":"FLIM-FRET in HEK cells; electrophysiology in Xenopus oocytes and HEK cells; isoform specificity controls (ClC-7, ClC-1 unaffected)","pmids":["39202776"],"confidence":"High","gaps":["TMEM9B stoichiometry and binding interface not determined","In vivo significance of TMEM9B regulation not tested"]},{"year":2025,"claim":"Discovery that certain CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers provided a molecular explanation for severe phenotypes in heterozygous females carrying X-linked mutations.","evidence":"Two-electrode voltage-clamp and whole-cell patch-clamp with bicistronic IRES co-expression of ClC-3 and ClC-4 variants","pmids":["41439993"],"confidence":"Medium","gaps":["Structural basis of dominant-negative effect unknown","Not all pathogenic variants tested for dominant-negative activity"]},{"year":2025,"claim":"Clcn4 KO mice exhibit autism-like behaviors, abnormal dendritic morphology, and reduced synaptic signaling (SYNAPSIN, PSD95, ERK, CREB phosphorylation), establishing a direct in vivo role for ClC-4 in synaptic plasticity and neural circuit function.","evidence":"Clcn4 KO mice; behavioral testing; Sholl analysis; immunoblot of signaling proteins; cortical neuron culture","pmids":["39863599"],"confidence":"Medium","gaps":["Causal link between endosomal acidification defect and synaptic signaling changes not established","Cell-type-specific requirements for ClC-4 in the brain not delineated"]},{"year":null,"claim":"A high-resolution structure of ClC-4 (alone or as a ClC-3/ClC-4 heterodimer) is lacking, and the molecular basis of how endosomal pH changes translate into synaptic and neurodevelopmental dysfunction remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or X-ray structure of ClC-4 or ClC-3/ClC-4 heterodimer","Mechanism linking endosomal acidification defect to dendritic and synaptic pathology unclear","Native tissue stoichiometry and interactome of ClC-3/ClC-4 heterodimers in neurons undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,3,4,11]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7,10]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,9,10]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,9,10]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,4,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,12,14,17]}],"complexes":["ClC-3/ClC-4 heterodimer"],"partners":["CLCN3","CLCN5","TMEM9B","ATP7B"],"other_free_text":[]},"mechanistic_narrative":"CLCN4 encodes ClC-4, a vesicular 2Cl⁻/H⁺ antiporter that acidifies endosomal compartments to support transferrin receptor recycling, iron release, and copper incorporation into ceruloplasmin [PMID:16034421, PMID:19339555, PMID:15057754]. When expressed alone, ClC-4 is retained in the endoplasmic reticulum via an N-terminal targeting motif (aa 14–63), but heterodimerization with ClC-3 splice variants redirects it to recycling endosomes or late endosomes/lysosomes, with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers [PMID:17023393, PMID:28972156]. The accessory protein TMEM9B directly interacts with and inhibits ClC-4 transporter activity, providing an additional layer of regulation [PMID:39202776]. Pathogenic CLCN4 variants cause X-linked neurodevelopmental disease including epilepsy and developmental encephalopathy through loss-of-function, gain-of-function, or dominant-negative mechanisms within ClC-3/ClC-4 heterodimers [PMID:36385166, PMID:35721313, PMID:41439993]."},"prefetch_data":{"uniprot":{"accession":"P51793","full_name":"H(+)/Cl(-) exchange transporter 4","aliases":["Chloride channel protein 4","ClC-4","Chloride transporter ClC-4"],"length_aa":760,"mass_kda":84.9,"function":"Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons (PubMed:18063579, PubMed:23647072, PubMed:25644381, PubMed:27550844, PubMed:28972156). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (PubMed:29845874). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (PubMed:29845874)","subcellular_location":"Early endosome membrane; Late endosome membrane; Endoplasmic reticulum membrane; Lysosome membrane; Recycling endosome membrane","url":"https://www.uniprot.org/uniprotkb/P51793/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLCN4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLCN4","total_profiled":1310},"omim":[{"mim_id":"615400","title":"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO5","url":"https://www.omim.org/entry/615400"},{"mim_id":"600580","title":"CHLORIDE CHANNEL 3; CLCN3","url":"https://www.omim.org/entry/600580"},{"mim_id":"302910","title":"CHLORIDE CHANNEL 4; CLCN4","url":"https://www.omim.org/entry/302910"},{"mim_id":"300552","title":"MIDLINE 1; MID1","url":"https://www.omim.org/entry/300552"},{"mim_id":"300114","title":"RAYNAUD-CLAES SYNDROME; MRXSRC","url":"https://www.omim.org/entry/300114"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":27.3},{"tissue":"retina","ntpm":35.1},{"tissue":"skeletal muscle","ntpm":41.9},{"tissue":"tongue","ntpm":32.0}],"url":"https://www.proteinatlas.org/search/CLCN4"},"hgnc":{"alias_symbol":["CLC4","ClC-4"],"prev_symbol":[]},"alphafold":{"accession":"P51793","domains":[{"cath_id":"1.10.3080.10","chopping":"80-307","consensus_level":"medium","plddt":89.2624,"start":80,"end":307},{"cath_id":"1.10.3080.10","chopping":"333-368_429-578","consensus_level":"high","plddt":89.8486,"start":333,"end":578},{"cath_id":"3.10.580.20","chopping":"595-749","consensus_level":"high","plddt":86.6388,"start":595,"end":749}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51793","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51793-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51793-F1-predicted_aligned_error_v6.png","plddt_mean":84.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLCN4","jax_strain_url":"https://www.jax.org/strain/search?query=CLCN4"},"sequence":{"accession":"P51793","fasta_url":"https://rest.uniprot.org/uniprotkb/P51793.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51793/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51793"}},"corpus_meta":[{"pmid":"16034421","id":"PMC_16034421","title":"Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16034421","citation_count":376,"is_preprint":false},{"pmid":"9873029","id":"PMC_9873029","title":"Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9873029","citation_count":208,"is_preprint":false},{"pmid":"12746443","id":"PMC_12746443","title":"The chloride channel ClC-4 contributes to endosomal acidification and trafficking.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12746443","citation_count":85,"is_preprint":false},{"pmid":"7670496","id":"PMC_7670496","title":"Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice.","date":"1995","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7670496","citation_count":72,"is_preprint":false},{"pmid":"27550844","id":"PMC_27550844","title":"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27550844","citation_count":57,"is_preprint":false},{"pmid":"12668439","id":"PMC_12668439","title":"Anion permeation in human ClC-4 channels.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12668439","citation_count":49,"is_preprint":false},{"pmid":"11882671","id":"PMC_11882671","title":"Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11882671","citation_count":48,"is_preprint":false},{"pmid":"11675385","id":"PMC_11675385","title":"The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11675385","citation_count":47,"is_preprint":false},{"pmid":"19546591","id":"PMC_19546591","title":"Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.","date":"2009","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19546591","citation_count":28,"is_preprint":false},{"pmid":"36385166","id":"PMC_36385166","title":"Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36385166","citation_count":27,"is_preprint":false},{"pmid":"15057754","id":"PMC_15057754","title":"Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin.","date":"2004","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15057754","citation_count":27,"is_preprint":false},{"pmid":"17023393","id":"PMC_17023393","title":"The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17023393","citation_count":27,"is_preprint":false},{"pmid":"33951195","id":"PMC_33951195","title":"The molecular and phenotypic spectrum of CLCN4-related epilepsy.","date":"2021","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/33951195","citation_count":25,"is_preprint":false},{"pmid":"28972156","id":"PMC_28972156","title":"Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28972156","citation_count":24,"is_preprint":false},{"pmid":"19339555","id":"PMC_19339555","title":"An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19339555","citation_count":21,"is_preprint":false},{"pmid":"21282478","id":"PMC_21282478","title":"Clcn4-2 genomic structure differs between the X locus in Mus spretus and the autosomal locus in Mus musculus: AT motif enrichment on the X.","date":"2011","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/21282478","citation_count":18,"is_preprint":false},{"pmid":"18658230","id":"PMC_18658230","title":"Insights into the ClC-4 transport mechanism from studies of Zn2+ inhibition.","date":"2008","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18658230","citation_count":16,"is_preprint":false},{"pmid":"35721313","id":"PMC_35721313","title":"Functional Characterization of CLCN4 Variants Associated With X-Linked Intellectual Disability and Epilepsy.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35721313","citation_count":13,"is_preprint":false},{"pmid":"34479510","id":"PMC_34479510","title":"Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report.","date":"2021","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34479510","citation_count":12,"is_preprint":false},{"pmid":"39863599","id":"PMC_39863599","title":"Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD.","date":"2025","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/39863599","citation_count":8,"is_preprint":false},{"pmid":"37359369","id":"PMC_37359369","title":"Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37359369","citation_count":8,"is_preprint":false},{"pmid":"39202776","id":"PMC_39202776","title":"TMEM9B Regulates Endosomal ClC-3 and ClC-4 Transporters.","date":"2024","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39202776","citation_count":7,"is_preprint":false},{"pmid":"37789889","id":"PMC_37789889","title":"Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37789889","citation_count":6,"is_preprint":false},{"pmid":"38578438","id":"PMC_38578438","title":"Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy.","date":"2024","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38578438","citation_count":5,"is_preprint":false},{"pmid":"38758281","id":"PMC_38758281","title":"Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients.","date":"2024","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38758281","citation_count":4,"is_preprint":false},{"pmid":"37271660","id":"PMC_37271660","title":"Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report.","date":"2023","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/37271660","citation_count":2,"is_preprint":false},{"pmid":"37409888","id":"PMC_37409888","title":"Prenatal diagnosis of CLCN4-related neurodevelopmental disorder in fetuses with congenital brain anomalies.","date":"2023","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/37409888","citation_count":2,"is_preprint":false},{"pmid":"38482266","id":"PMC_38482266","title":"Experience with the Ketogenic Diet in a Boy with CLCN4 Related Neurodevelopmental Disorder.","date":"2024","source":"Balkan journal of medical genetics : BJMG","url":"https://pubmed.ncbi.nlm.nih.gov/38482266","citation_count":2,"is_preprint":false},{"pmid":"37671947","id":"PMC_37671947","title":"Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37671947","citation_count":1,"is_preprint":false},{"pmid":"37730231","id":"PMC_37730231","title":"[Analysis of CLCN4 gene variant in a child with Raynaud-Claes syndrome].","date":"2023","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37730231","citation_count":0,"is_preprint":false},{"pmid":"41439993","id":"PMC_41439993","title":"Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41439993","citation_count":0,"is_preprint":false},{"pmid":"40800199","id":"PMC_40800199","title":"Clinical features and genetic analysis of epilepsy caused by CLCN4 gene mutation: a case report and literature review.","date":"2025","source":"Translational pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/40800199","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.16.665078","title":"<i>MEG3</i> Enhances Survival of Developing Human Neurons with <i>CLCN4</i>-Linked Autophagy Impairment","date":"2025-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.16.665078","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.29.610281","title":"Integrative transcriptomics and electrophysiological profiling of hiPSC-derived neurons identifies novel druggable pathways in Koolen-de Vries Syndrome","date":"2024-08-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.29.610281","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18367,"output_tokens":4233,"usd":0.059298},"stage2":{"model":"claude-opus-4-6","input_tokens":7720,"output_tokens":3147,"usd":0.175912},"total_usd":0.23521,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"ClC-4 functions as a secondary active Cl⁻/H⁺ antiporter (not a classical Cl⁻ channel), transporting protons against their electrochemical gradient coupled to Cl⁻ movement; mutation of the pore glutamate E211A abolishes H⁺ but not Cl⁻ transport, identifying this residue as essential for proton transport.\",\n      \"method\": \"pH measurements near cell surface in Xenopus oocytes; site-directed mutagenesis (E211A) with electrophysiology\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with mutagenesis, highly cited foundational paper\",\n      \"pmids\": [\"16034421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ClC-4 directly mediates strongly outwardly rectifying anion currents with a NO₃⁻ > Cl⁻ > Br⁻ > I⁻ conductance sequence; point mutations (including E224A in ClC-4) alter voltage dependence and ion selectivity, confirming direct channel-mediated currents.\",\n      \"method\": \"Xenopus oocyte and HEK293 electrophysiology; site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiology with mutagenesis, highly cited\",\n      \"pmids\": [\"9873029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ClC-4 is expressed in endosomal membranes; antisense-mediated disruption of endogenous ClC-4 acidifies endosomal pH and alters transferrin trafficking; ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they may function as a channel complex in endosomes.\",\n      \"method\": \"Confocal microscopy; antisense knockdown; endosomal pH measurement; co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (co-IP, KD with functional readout, imaging) in single lab\",\n      \"pmids\": [\"12746443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ClC-4 exhibits unique pore properties including voltage-dependent unitary conductance (~0.10 pA at +140 mV) and distinct conductivity/permeability sequences for anions, with permeability increasing for anions with lower dehydration energies.\",\n      \"method\": \"Whole-cell patch-clamp recording; variance analysis; ion substitution experiments in tsA201/HEK293 cells\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative single-channel and macroscopic electrophysiology with multiple ion conditions\",\n      \"pmids\": [\"12668439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Recombinant human ClC-4 generates a small-conductance (~3 pS), strongly outward-rectifying Cl⁻ channel whose activity requires ATP (with hydrolysis needed for full activity); external acidification inhibits currents with half-maximal inhibition at ~pH 6.19; Ca²⁺ has no effect.\",\n      \"method\": \"Patch-clamp electrophysiology in multiple mammalian cell lines; single-channel recordings; nucleotide substitution experiments\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed electrophysiological characterization with multiple pharmacological and ionic conditions\",\n      \"pmids\": [\"11882671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ClC-4 co-localizes with CFTR in the brush border membrane of intestinal epithelial cells and partially with endosomal markers; antisense knockdown of endogenous ClC-4 reduces Cl⁻ current amplitude by 50%, demonstrating functional expression at the plasma membrane of enterocytes.\",\n      \"method\": \"Confocal and electron microscopy; antisense knockdown; electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence via knockdown electrophysiology\",\n      \"pmids\": [\"11675385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ClC-4 promotes copper incorporation into ceruloplasmin; ClC-4 overexpression doubles holoCp secretion (more than 4-fold under copper-limiting conditions), while ClC-3 overexpression has no effect; ClC-4 co-immunoprecipitates with ATP7B (Wilson's disease protein) and co-localizes with it in intracellular vesicles.\",\n      \"method\": \"Co-overexpression with ceruloplasmin; gel electrophoresis/immunoblot; co-immunoprecipitation; subcellular fractionation/confocal microscopy\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional overexpression assay with specific isoform controls\",\n      \"pmids\": [\"15057754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human ClC-4 localizes to the endoplasmic reticulum/sarcoplasmic reticulum (not vesicular structures like ClC-3) when heterologously expressed; a stretch of N-terminal residues (aa 14–63) constitutes a novel motif necessary and sufficient for ER targeting.\",\n      \"method\": \"Heterologous expression in HEK293 and skeletal muscle fibers; subcellular fractionation; truncation and chimera constructs; confocal imaging\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — localization determined by direct fractionation and imaging, with structure-function mapping via chimeras/truncations\",\n      \"pmids\": [\"17023393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zn²⁺ inhibits ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site involving three consecutive histidine residues in an extracellular loop; mutations of these histidines reduce Zn²⁺ inhibition; alterations of transport properties (permeant ions, gating glutamate mutation) also affect Zn²⁺ inhibition.\",\n      \"method\": \"Xenopus oocyte electrophysiology; site-directed mutagenesis of candidate histidine residues; ion substitution\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of multiple candidate residues with quantitative functional assays\",\n      \"pmids\": [\"18658230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ClC-4-null fibroblasts show alkaline endosomal pH, reduced transferrin (Tfn) receptor-mediated uptake despite slightly increased Tfn receptor surface expression; the iron-release defect (a pH-dependent step) can be rescued by the iron chelator deferoxamine; ClC-4 depletion has no effect on EGFR trafficking to lysosomes, demonstrating a specific role in recycling endosomes.\",\n      \"method\": \"Primary fibroblasts from Clcn4-null mice; endosomal pH measurement; transferrin uptake assays; surface biotinylation; deferoxamine rescue; EGF trafficking comparison\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO model with multiple orthogonal readouts and specific rescue experiment\",\n      \"pmids\": [\"19339555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ClC-4 is retained in the ER upon overexpression alone but is sorted to late endosomes/lysosomes or recycling endosomes depending on which ClC-3 splice variant it heterodimerizes with; in Clcn3-null astrocytes, ClC-4 is retained in the ER; native gel electrophoresis shows ClC-4 mostly as monomer with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers.\",\n      \"method\": \"Heterologous expression; confocal imaging in WT and Clcn3⁻/⁻ astrocytes; high-resolution clear native gel electrophoresis; co-expression of ClC-3 splice variants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, epistasis via Clcn3 KO, biochemical oligomerization analysis\",\n      \"pmids\": [\"28972156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pathogenic CLCN4 missense variants cause either loss-of-function (voltage-dependent activation shifted to more positive voltages) or gain-of-function (disrupted gate allowing inward transport at negative voltages); 15/59 variants showed LOF and 9 showed toxic GOF by electrophysiology.\",\n      \"method\": \"Xenopus oocyte two-electrode voltage-clamp; extended voltage and pH ranges; functional analysis of 59 variants\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — large-scale electrophysiological functional analysis across 59 variants with mechanistic classification\",\n      \"pmids\": [\"36385166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Disease-causing CLCN4 mutations can impair ClC-4 ion transport, alter subcellular trafficking, and/or impair heterodimerization with ClC-3; even subtle functional changes to endosomal Cl⁻/H⁺ exchange cause serious neurological symptoms.\",\n      \"method\": \"Heterologous expression in mammalian cells; patch-clamp electrophysiology; biochemistry; confocal imaging; analysis of 12 CLCN4 variants\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across many variants in mammalian cells\",\n      \"pmids\": [\"35721313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TMEM9B directly interacts with ClC-3 and ClC-4 transporters (demonstrated by FLIM-FRET), and co-expression of TMEM9B dramatically reduces ClC-3 and ClC-4 transporter activity in Xenopus oocytes and HEK cells, while having little effect on ClC-7 or ClC-1, identifying TMEM9B as a specific regulatory accessory subunit for ClC-3/ClC-4.\",\n      \"method\": \"Xenopus oocyte electrophysiology; whole-cell patch-clamp in HEK cells; FLIM-FRET; co-expression studies\",\n      \"journal\": \"Life (Basel, Switzerland)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FRET-based direct interaction evidence combined with functional electrophysiology in two systems with isoform specificity controls\",\n      \"pmids\": [\"39202776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Certain pathogenic CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing transport activity of the heteromeric complex; this provides a molecular explanation for severe phenotypes in heterozygous females.\",\n      \"method\": \"Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in mammalian cells; bicistronic IRES co-expression of ClC-3 and ClC-4 variants\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — functional electrophysiology in two systems, single lab, novel mechanistic finding\",\n      \"pmids\": [\"41439993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLCN4 variants in human neurons cause early-stage neuronal cell death associated with altered endo-lysosomal dynamics and disrupted autophagic flux; MEG3 lncRNA is downregulated in CLCN4-variant neurons and its restoration rescues cellular defects and neuronal survival.\",\n      \"method\": \"Brain organoids and iPSC-derived neurons with patient CLCN4 variants; transcriptomic profiling; MEG3 rescue experiments; autophagic flux assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, single lab, novel pathway (autophagy/MEG3) not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.07.16.665078\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Clcn4 knockout mice display reduced social interaction, increased repetitive behaviors, abnormal dendritic spine formation, reduced dendritic branching, and decreased phosphorylation of SYNAPSIN, PSD95, ERK, and CREB, as well as reduced CDK5 expression, demonstrating a role for ClC-4 in synaptic plasticity and neuronal morphology.\",\n      \"method\": \"Clcn4 KO mice (exon 5 deletion); behavioral tests; RNA-seq of mouse NPCs; immunoblot; Sholl analysis; cortical neuron culture\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO model with multiple biochemical and morphological readouts, single lab\",\n      \"pmids\": [\"39863599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The CLCN4 p.(Gly342Arg) variant impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of transport activation by ~20 mV, with p.(Asp89Asn) constituting a gain-of-transport-function variant, demonstrating that both LOF and GOF ClC-4 variants cause epilepsy and developmental encephalopathy.\",\n      \"method\": \"Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, single lab, clear mechanistic distinctions between variants\",\n      \"pmids\": [\"38578438\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ClC-4 is a vesicular 2Cl⁻/H⁺ antiporter that localizes to the endoplasmic reticulum when expressed alone but is sorted to distinct endosomal compartments (recycling endosomes, late endosomes/lysosomes) upon heterodimerization with specific ClC-3 splice variants; its antiporter activity requires a critical pore glutamate (E211), is regulated by the accessory protein TMEM9B, acidifies endosomal lumen to support transferrin receptor cycling and copper incorporation into ceruloplasmin, and pathogenic CLCN4 variants cause neurodevelopmental disease through loss-of-function, gain-of-function, or dominant-negative effects within ClC-3/ClC-4 heterodimers.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLCN4 encodes ClC-4, a vesicular 2Cl⁻/H⁺ antiporter that acidifies endosomal compartments to support transferrin receptor recycling, iron release, and copper incorporation into ceruloplasmin [PMID:16034421, PMID:19339555, PMID:15057754]. When expressed alone, ClC-4 is retained in the endoplasmic reticulum via an N-terminal targeting motif (aa 14–63), but heterodimerization with ClC-3 splice variants redirects it to recycling endosomes or late endosomes/lysosomes, with ClC-3–ClC-4 heterodimers being more stable than ClC-4 homodimers [PMID:17023393, PMID:28972156]. The accessory protein TMEM9B directly interacts with and inhibits ClC-4 transporter activity, providing an additional layer of regulation [PMID:39202776]. Pathogenic CLCN4 variants cause X-linked neurodevelopmental disease including epilepsy and developmental encephalopathy through loss-of-function, gain-of-function, or dominant-negative mechanisms within ClC-3/ClC-4 heterodimers [PMID:36385166, PMID:35721313, PMID:41439993].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that ClC-4 directly conducts strongly outwardly rectifying anion currents with a defined selectivity sequence resolved whether the protein was itself an ion-conducting entity or merely a regulator.\",\n      \"evidence\": \"Xenopus oocyte and HEK293 electrophysiology with site-directed mutagenesis (E224A)\",\n      \"pmids\": [\"9873029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transport stoichiometry and whether H⁺ coupling occurs were not addressed\", \"Native cellular context not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Detailed biophysical characterization revealed that ClC-4 requires ATP for full activity and is inhibited by extracellular acidification, establishing regulatory parameters relevant to endosomal function.\",\n      \"evidence\": \"Patch-clamp electrophysiology with single-channel recordings and nucleotide substitution in mammalian cells\",\n      \"pmids\": [\"11882671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ATP acts directly on the protein or through a signaling intermediate was not resolved\", \"Physiological relevance of pH inhibition in endosomes not yet tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Localization of ClC-4 to endosomal membranes and demonstration that its depletion alkalinizes endosomal pH and impairs transferrin trafficking established ClC-4 as a functionally important endosomal transporter.\",\n      \"evidence\": \"Confocal microscopy, antisense knockdown, endosomal pH measurement, and co-immunoprecipitation with ClC-5\",\n      \"pmids\": [\"12746443\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Antisense approach lacks genetic specificity\", \"Co-IP with ClC-5 not validated by reciprocal pull-down or in-vivo crosslinking\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that ClC-4 promotes copper loading of ceruloplasmin and co-immunoprecipitates with the copper transporter ATP7B revealed a specific role in metal homeostasis distinct from ClC-3.\",\n      \"evidence\": \"Overexpression of ClC-4 vs. ClC-3 with ceruloplasmin; co-IP with ATP7B; confocal co-localization\",\n      \"pmids\": [\"15057754\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Loss-of-function validation of copper phenotype not performed\", \"Co-IP without reciprocal validation\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Reclassification of ClC-4 from a Cl⁻ channel to a secondary active Cl⁻/H⁺ antiporter — with identification of E211 as the critical proton-coupling glutamate — fundamentally redefined its molecular mechanism.\",\n      \"evidence\": \"pH measurements near cell surface in Xenopus oocytes; E211A mutagenesis with electrophysiology\",\n      \"pmids\": [\"16034421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transport stoichiometry not directly determined for ClC-4\", \"Reconstitution in proteoliposomes not performed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapping an N-terminal ER-retention motif (aa 14–63) explained why ClC-4 localizes to the ER when expressed alone, raising the question of what mechanism reroutes it to endosomes in vivo.\",\n      \"evidence\": \"Truncation and chimera constructs with confocal imaging and subcellular fractionation in HEK293 and skeletal muscle fibers\",\n      \"pmids\": [\"17023393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Partner-dependent re-routing not yet identified\", \"ER retention motif sequence determinants not mapped to specific residues\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of an extracellular Zn²⁺ inhibition site involving three consecutive histidines provided the first structural insight into ClC-4 regulation by divalent cations.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology with systematic histidine mutagenesis and ion substitution\",\n      \"pmids\": [\"18658230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of Zn²⁺ inhibition in endosomal lumen not established\", \"No structural data to confirm binding site geometry\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Clcn4-knockout fibroblasts with alkalinized endosomes and impaired transferrin uptake — but normal EGF/lysosome trafficking — genetically confirmed a specific role for ClC-4 in recycling-endosome acidification and iron release.\",\n      \"evidence\": \"Clcn4-null mouse primary fibroblasts; endosomal pH measurement; transferrin and EGF trafficking assays; deferoxamine rescue\",\n      \"pmids\": [\"19339555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo neuronal phenotype not assessed in this study\", \"Contribution of ClC-3 compensation not evaluated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that ClC-3 splice variants redirect ClC-4 from the ER to distinct endosomal compartments via heterodimerization resolved the long-standing puzzle of ClC-4's ER retention and established ClC-3/ClC-4 heterodimers as the physiologically relevant species.\",\n      \"evidence\": \"Co-expression in WT and Clcn3⁻/⁻ astrocytes; clear native gel electrophoresis; confocal imaging\",\n      \"pmids\": [\"28972156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants within ClC-3 that dictate sorting destination not mapped\", \"Endogenous stoichiometry of heterodimers vs. homodimers in neurons unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematic electrophysiological analysis of 59 pathogenic CLCN4 variants established that neurodevelopmental disease arises through mechanistically distinct loss-of-function and gain-of-function mechanisms, explaining clinical heterogeneity.\",\n      \"evidence\": \"Xenopus oocyte two-electrode voltage-clamp of 59 variants; extended voltage and pH protocols\",\n      \"pmids\": [\"36385166\", \"35721313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Correlation between variant class and clinical severity not fully resolved\", \"Effects on ClC-3/ClC-4 heterodimer function not assessed for all variants\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of TMEM9B as a direct interactor that specifically inhibits ClC-3/ClC-4 transport revealed a previously unknown accessory subunit-based regulatory mechanism for endosomal Cl⁻/H⁺ exchange.\",\n      \"evidence\": \"FLIM-FRET in HEK cells; electrophysiology in Xenopus oocytes and HEK cells; isoform specificity controls (ClC-7, ClC-1 unaffected)\",\n      \"pmids\": [\"39202776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TMEM9B stoichiometry and binding interface not determined\", \"In vivo significance of TMEM9B regulation not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that certain CLCN4 variants exert dominant-negative effects within ClC-3/ClC-4 heterodimers provided a molecular explanation for severe phenotypes in heterozygous females carrying X-linked mutations.\",\n      \"evidence\": \"Two-electrode voltage-clamp and whole-cell patch-clamp with bicistronic IRES co-expression of ClC-3 and ClC-4 variants\",\n      \"pmids\": [\"41439993\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of dominant-negative effect unknown\", \"Not all pathogenic variants tested for dominant-negative activity\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Clcn4 KO mice exhibit autism-like behaviors, abnormal dendritic morphology, and reduced synaptic signaling (SYNAPSIN, PSD95, ERK, CREB phosphorylation), establishing a direct in vivo role for ClC-4 in synaptic plasticity and neural circuit function.\",\n      \"evidence\": \"Clcn4 KO mice; behavioral testing; Sholl analysis; immunoblot of signaling proteins; cortical neuron culture\",\n      \"pmids\": [\"39863599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between endosomal acidification defect and synaptic signaling changes not established\", \"Cell-type-specific requirements for ClC-4 in the brain not delineated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of ClC-4 (alone or as a ClC-3/ClC-4 heterodimer) is lacking, and the molecular basis of how endosomal pH changes translate into synaptic and neurodevelopmental dysfunction remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or X-ray structure of ClC-4 or ClC-3/ClC-4 heterodimer\", \"Mechanism linking endosomal acidification defect to dendritic and synaptic pathology unclear\", \"Native tissue stoichiometry and interactome of ClC-3/ClC-4 heterodimers in neurons undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 3, 4, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 9, 10]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 9, 10]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 4, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 12, 14, 17]}\n    ],\n    \"complexes\": [\n      \"ClC-3/ClC-4 heterodimer\"\n    ],\n    \"partners\": [\n      \"CLCN3\",\n      \"CLCN5\",\n      \"TMEM9B\",\n      \"ATP7B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}